Extensive personal, experience: Adrenocortical tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1317-1324

  Latronico, Ana C ^a,c   Chrousos, George P ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; COTTON SEED OIL; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GOSSYPOL; MELPHALAN; MITOTANE; SURAMIN; VINCRISTINE;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; CUSHING SYNDROME; FEMINIZATION; HISTOPATHOLOGY; HUMAN; HYPERALDOSTERONISM; LABORATORY TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SOMNOLENCE; TUMOR CLASSIFICATION; VIRILIZATION;

EID: 0030969125     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.5.3921     Document Type: Article

References (50)

1. Ross NS, Aron DC. 1940 Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med. 323:1401-1405.
2. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. 1995 Incidentally discovered adrenal masses. Endocr Rev. 16:460-483.
3. Flack MR, Chrousos GP. 1996 Neoplasms of the adrenal cortex. In: Holland R, ed. Cancer Medicine, 4th ed. New York: Lea and Fibinger; pp 1563-1570.
4. Chudler RM, Kay R. 1989 Adrenocortical carcinoma in children. Urol Clin North Am. 16:469-479.
5. Mendonca BB, Lucon AM, Menezes CAV, et al. 1945 Clinical, hormonal and pathological findings in a comparative study of adrenal cortical neoplasms in childhood and adulthood. J Urol. 154:2004-2009.
6. Luton JP, Cerdas S, Billaud L, et al. 1990 Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med. 322:1195-1201.
7. Barzilay JI, Pazianos AG. 1989 Adrenocortical carcinoma. Urol Clin North Am. 16:457-468.
8. Pommier RF, Brennan MF. 1992 An eleven-year experience with adrenocortical carcinoma. Surgery. 112:963-971.
9. Crapo L. 1979 Cushing's syndrome: a review of diagnostic tests. Metabolism. 28:955-977.
10. Freeman DA. 1978 Steroid hormone-producing tumors in man. Endocr Rev. 7:204-220.
11. Shapiro B, Fig LM, Gross MD, Khafagi F. 1990 Contributions of nuclear endocrinology to the diagnosis of adrenal tumors. Recents Results Cancer Res. 118:113-138.
12. Weiss LM. 1984 Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol. 8:163-169.
13. Bowlby LS, DeBault L, Abraham SR. 1986 Flow cytometric analysis of adrenal cortical tumor DNA. Cancer. 58:1499-1505.
14. Taylor S, Roederer M, Murphy R. 1987 Flow cytometric DNA analysis of adrenocortical tumors in children. Cancer. 59:2059-2063.
15. Macfarlane DA. 1958 Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Sur Engl. 23:155-186.
16. Beuschlein F, Reincke M, Karl M, et al. 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res. 54:4927-4932.
17. Gicquel C, Leblond-Francillard M, Bertagna X, et al. 1994 Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf). 40:465-477.
18. Ping AP, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP. 1989 Genetic linkage of Beckwith-Wiedmann syndrome to 11p15. Am J Hum Genet. 44:720-723.
19. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. 1985 Loss of heterozygosity in three embryonal tumours suggests a common pathogenic mechanism. Nature. 316:330-334.
20. Gicquel C, Xavier B, Schneid H, et al. 1994 Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab. 78:1444-1453.
21. Yano T, Linehan M, Anglard P, et al. 1989 Genetic changes in human adrenocortical carcinoma. J Natl Cancer Inst. 81:518-523.
22. Gicquel C, Bertagna X, Bouc YL. 1995 Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol. 133:133-144.
23. Reincke M, Karl M, Travis WH, et al. 1994 p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab. 78:790-794.
24. Rosenberg C, Della-Rosa VA, Latronico AC, Mendonca BB, Vianna-Morgante AM. 1995 Selection of adrenal tumor cells in culture demonstrated by interphase cytogenetics. Cancer Genet Cytogenet. 79:36-40.
25. Stratakis CA, Carney JA, Lin J-P, et al. 1996 Carney complex: a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds nad linkage to the short arm of chromosome 2. J Clin Invest. 97:599-607.
26. Stratakis CA, Jenkins RB, Pras E, et al. 1996 Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, endocrine overactivity (Carney complex). J Clin Endocrinol Metab. 81:3607-3614.
27. Skogseid B, Larsson C, Lindgren PG, et al. 1992 Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 75:76-81.
28. Mountjoy KG, Robbins LS, Marty TM, Cone RD. 1992 The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1248-1251.
29. Vamvakopoulos NC, Rojas K, Overhauser, Durkin S, Nierman WC, Chrousos GP. 1943 Mapping the human melanocortin 2 receptor (adrenocorticotropic hormone receptor; ACTHR) gene (MCR2) to the small arm of chromosome 18 (18p11.21-pter). Genomics. 18:454-455.
30. Latronico AC, Reincke M, Mendonça BB, et al. 1995 No evidence for oncogenic mutations in the adrenocorticotropin receptor (ACTH-R) gene in human adrenocortical neoplasms. J Clin Endocrinol Metab. 80:875-877.
31. Light K, Jenkins PJ, Weber A, et al. 1995 Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia? Life Sci. 56: 1523-1527.
32. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel A. 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 325:1688-1695.
33. Lyons J, Landid CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
34. Reincke M, Karl M, Travis W, Chrousos GP. 1993 No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab. 77:1419-1422.
35. Cicquel C, Dib A, Bertagna X, Amselem S, Bouc YL. 1995 Oncogenic mutations of α-Gi2 protein are not determinant for human adrenocortical tumourigenesis. Eur J Endocrinol. 133:166-172.
36. Latronico AC, Mendonça BB, Bianco AC, et al. 1994 Calcium-dependent protein kinase-C activity in human adrenocortical neoplasms, hyperplastic adrenals, and normal adrenocortical tissue. J Clin Endocrinol Metab. 79:736-739.
37. Yashiro T, Hara H, Fulton NC, Obara T, Kaplan EL. 1994 Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia. World J Surg. 18:455-461.
38. Moul JW, Bishoff JT, Theune SM, Chang EH. 1993 Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytoma. J Urol. 149:1389-1394.
39. Lin SR, Lee YJ, Tsai JH. 1994 Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab. 78:483-491.
40. Reincke M, Wachenfeld C, Mora P, et al. 1996 p53 mutations in adrenal tumors: caucasian patients do not show exon 4 "hot spot" found in Taiwan. J Clin Endocrinol Metab. 81:3636-3668.
41. Warneford S, Townsend M, Rowe PB, Dalla-Pozza L, Symonds G. 1991 Overexpression of the retinoblstoma gene in a familial adrenocortical carcinoma. Cell Growth Differ. 2:439-445.
42. Lin D, Sugawara T, Strauss JF 3rd, et al. 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 267:1780-1781.
43. Liu J, Heikkila P, Kahri AI, Voutilainen R. 1996 Expression of the steroidogenic acute regulatory protein mRNA in adrenal tumors and cultured adrenal cells. J Endocrinol. 150:43-50.
44. Luo X, Ikeda Y, Parker K. 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 77:481-490.
45. Wong M, Ramayya MS, Chrousos GP, Driggers PH, Parker KL. 1996 Cloning and sequence analysis of the human gene encoding steroidogenic factor. J Mol Endocrinol. 17:139-147.
46. Muscatelli F, Strom TM, Walker AP, et al. 1994 Mutations in the DAX-1 gene give rise to both X-linked hypoplasia congenita and hypogonadotropic hypogonadism. Nature. 372:672-676.
47. Schteingart DE. 1992 Treating adrenal cancer. Endocrinologist. 2:149-157.
48. Flack MR, Pyle RG, Mullen NM, et al. 1993 Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab. 76:1019-1024.
49. Johnson DH, Greco FA. 1986 Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16). Cancer. 58:2198-2202.
50. Schlumberger M, Ostronoff M, Bellaiche M, Rougier P, Droz JP, Parmentier C. 1988 5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma. Cancer. 61:1492-1494.